Applied Biosystems announced this week the launch of the TaqMan OpenArray Genotyping System, a new analysis platform that allows researchers to perform faster and more cost-effective high-sample-throughput genotyping studies, the company said.
“This system expands the potential uses of TaqMan technology across a wide range of genotyping applications, providing an extremely fast, high-sample-throughput validation and screening tool for researchers in agricultural, pharmaceutical, and other commercial industries, as well as academic institutions,” ABI said in a statement.
Using this platform, which was developed as part of a collaboration between ABI and BioTrove, researchers can analyze “thousands to tens of thousands of samples in days, in contrast to weeks or months on alternative genotyping platforms.”
Researchers can use this platform to associate genotypes with complex diseases, ethnic ancestry, drug response, as well as traits for breeding and quality control in agricultural studies.
ABI holds the exclusive rights to develop and market custom-built OpenArray plates of TaqMan SNP Genotyping Assays.